lormed
pro. med. cs praha a.s. - meloksikamas - tabletės - 7,5 mg; 15 mg - meloxicam
proindap
pro. med. cs praha a.s. - indapamidas - kietosios kapsulės - 2,5 mg - indapamide
propanorm
pro. med. cs praha a.s. - propafenono hidrochloridas - plėvele dengtos tabletės - 3,5 mg/ml; 150 mg; 300 mg - propafenone
prosulpin
pro. med. cs praha a.s. - sulpiridas - tabletės - 200 mg - sulpiride
medicarine.
ecolab sp.z o.o., ul. opolska 114, pl-31323 krakow, lenkija. - troklozennatrio dihidratas, natrio dichlorizocianurato dihidratas, dicd - veikliosios medžiagos cas nr.: 51580-86-0, eb nr.: 220-767-7, veikliosios medžiagos pavadinimas: troklozennatrio dihidratas, natrio dichlorizocianurato dihidratas, dicd, koncentracija: 99.61% , veiklioji - maisto ir pašarų sritis
suma tab d4 tab.
diversey polska sp. z o.o., al. jerozolimskie 134, pl-02305 warszawa (lenkija). - troklozennatrio dihidratas, natrio dichlorizocianurato dihidratas, dicd - veikliosios medžiagos cas nr.: 51580-86-0, eb nr.: 220-767-7, veikliosios medžiagos pavadinimas: troklozennatrio dihidratas, natrio dichlorizocianurato dihidratas, dicd, koncentracija: 99.7% , veiklioji - maisto ir pašarų sritis
progit
pro. med. cs praha a.s. - itoprido hidrochloridas - plėvele dengtos tabletės - 50 mg - itropride
edistride
astrazeneca ab - dapagliflozino propanedilo monohidratas - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - narkotikai, vartojami diabetu - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. be kitų vaistų, skirtų gydyti 2 tipo cukrinis diabetas. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ir 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
forxiga
astrazeneca ab - dapagliflozino propanedilo monohidratas - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - narkotikai, vartojami diabetu - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. be kitų vaistų, skirtų gydyti 2 tipo cukrinis diabetas. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ir 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
monosan
pro. med. cs praha a.s. - izosorbido mononitratas - tabletės - 20 mg; 40 mg - isosorbide mononitrate